Intercell Receives Approval for Vaccine in India
Published: November 10, 2011; 18:52 · (Vindobona)
The Austrian pharmaceutical company achieved an important milestone in the roll-out of its Japanese Encephalitis vaccine in endemic countries.
Intercell Receives Approval for Vaccine in India / Picture: © Intercell
Intercell AG and its partner Biological E. Ltd. today announced the approval of their vaccine to protect children and adults from Japanese Encephalitis (JE) by the Drugs Controller General of India (DCGI).
As previously announced, the analysis of the pivotal Phase III safety and immunogenicity data showed positive results and the study met its primary endpoint. Through a rolling…
Fast News Search